BioLife Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . BioLife Solutions
BLFS Stock  USD 23.89  0.29  1.20%   
BioLife Solutions' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BioLife Solutions' valuation are provided below:
Gross Profit
64.4 M
Profit Margin
(0.03)
Market Capitalization
1.2 B
Enterprise Value Revenue
11.0435
Revenue
100.1 M
There are over one hundred nineteen available fundamental signals for BioLife Solutions, which can be analyzed over time and compared to other ratios. All traders should validate BioLife Solutions' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 1.1 B in 2026. Enterprise Value is likely to gain to about 1.1 B in 2026

BioLife Solutions Total Revenue

99.32 Million

Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 868.2 K, Selling General Administrative of 34.7 M or Total Revenue of 99.3 M, as well as many indicators such as Price To Sales Ratio of 15.88, Dividend Yield of 0.0014 or PTB Ratio of 3.74. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
  
Build AI portfolio with BioLife Stock
Check out the analysis of BioLife Solutions Correlation against competitors.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

BioLife Solutions Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets482.4 M459.4 M187.5 M
Slightly volatile
Other Current Liabilities14.9 M14.2 M7.2 M
Slightly volatile
Total Current Liabilities39.5 M37.6 M16.1 M
Slightly volatile
Accounts Payable2.1 M4.1 M3.5 M
Slightly volatile
Cash115.2 M109.7 M34.6 M
Slightly volatile
Other Assets466.3 M444.1 M153.9 M
Slightly volatile
Cash And Short Term Investments126.3 M120.3 M39.9 M
Slightly volatile
Common Stock Shares Outstanding55.6 M53 M24 M
Slightly volatile
Liabilities And Stockholders Equity482.4 M459.4 M187.5 M
Slightly volatile
Other Current Assets7.2 M6.9 M3.6 M
Slightly volatile
Other Stockholder Equity825.9 M786.5 M302.4 M
Slightly volatile
Total Liabilities61.1 M58.2 M29.5 M
Slightly volatile
Total Current Assets179.6 M171.1 M64.7 M
Slightly volatile
Non Current Liabilities Total21.5 M20.5 M13.5 M
Slightly volatile
Inventory35 M33.4 M14 M
Slightly volatile
Net Receivables11.1 M10.5 M7.8 M
Slightly volatile
Short Term Debt15 M14.3 M4.7 M
Slightly volatile
Short and Long Term Debt Total36.4 M34.7 M22.7 M
Pretty Stable
Common Stock Total Equity35.1 K38 K29.3 K
Very volatile
Common Stock37.1 K54 K33 K
Pretty Stable
Current Deferred Revenue112.5 K118.5 K269.2 K
Slightly volatile
Property Plant Equipment56.3 M53.6 M19.9 M
Slightly volatile
Other Liabilities2.8 M3 M8.4 M
Pretty Stable
Capital Surpluse365.4 M348 M174.1 M
Slightly volatile
Deferred Long Term Liabilities47.8 M45.5 M19.8 M
Slightly volatile
Non Current Liabilities Other2 M2.1 M4.9 M
Slightly volatile
Deferred Long Term Asset Charges146.1 K132.1 K120.7 K
Very volatile
Warrants1.1 M1.2 M1.3 M
Slightly volatile
Long Term Debt Total2.3 M2.6 M2.8 M
Slightly volatile
Long Term Investments4.9 M6.5 M3.8 M
Slightly volatile
Short and Long Term Debt13.2 M12.6 M4 M
Slightly volatile
Net Invested Capital262.4 M419.6 M156.5 M
Slightly volatile
Net Working Capital73.4 M133.4 M47 M
Slightly volatile
Capital Stock39.3 K54 K29.1 K
Slightly volatile
Capital Lease Obligations14.8 M16.4 M7.3 M
Slightly volatile

BioLife Solutions Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative34.7 M36.5 M17.9 M
Slightly volatile
Total Revenue99.3 M94.6 M44.7 M
Slightly volatile
Other Operating Expenses107.9 M102.8 M53.8 M
Slightly volatile
Cost Of Revenue34.5 M32.9 M26 M
Slightly volatile
Total Operating Expenses73.4 M69.9 M34.4 M
Slightly volatile
Research Development9.6 M9.1 M5.5 M
Slightly volatile
Selling And Marketing Expenses8.2 M8.6 M24.8 M
Slightly volatile
Interest Income63.4 K66.7 K78.8 K
Pretty Stable
Preferred Stock And Other Adjustments303.3 K389.9 K280.4 K
Slightly volatile
Reconciled Depreciation7.4 M10 M4.3 M
Slightly volatile
Non Recurring643.2 K601.2 K822.6 K
Slightly volatile

BioLife Solutions Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow42.8 M40.8 M20.6 M
Slightly volatile
End Period Cash Flow115.2 M109.7 M34.6 M
Slightly volatile
Stock Based Compensation19 M27.8 M22.4 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.8816.72118
Slightly volatile
Dividend Yield0.00140.0020.0017
Slightly volatile
Days Sales Outstanding44.4546.7965.1174
Pretty Stable
Average Payables396.1 K630.8 K649.8 K
Very volatile
Stock Based Compensation To Revenue0.410.430.1596
Slightly volatile
EV To Sales15.0215.81118
Slightly volatile
Inventory Turnover1.081.133.4321
Slightly volatile
Days Of Inventory On Hand236426193
Slightly volatile
Payables Turnover3.627.25.7134
Slightly volatile
Sales General And Administrative To Revenue0.540.570.4819
Pretty Stable
Average Inventory2.2 M2.1 M1.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.110.09620.1378
Pretty Stable
Capex To Revenue0.04290.04510.0836
Slightly volatile
Cash Per Share2.152.041.1462
Slightly volatile
Days Payables Outstanding49.8552.4768.7758
Slightly volatile
Intangibles To Total Assets0.320.50.4119
Slightly volatile
Current Ratio3.314.094.7433
Very volatile
Receivables Turnover8.0510.326.8893
Pretty Stable
Capex Per Share0.130.08060.1036
Slightly volatile
Average Receivables1 M955.3 K1 M
Slightly volatile
Revenue Per Share1.572.051.4172
Slightly volatile
Interest Debt Per Share0.540.60.7271
Pretty Stable
Debt To Assets0.06460.0680.8372
Slightly volatile
Graham Number3.013.663.6606
Slightly volatile
Operating Cycle326473252
Slightly volatile
Days Of Payables Outstanding49.8552.4768.7758
Slightly volatile
Quick Ratio3.734.213.9773
Pretty Stable
Cash Ratio1.72.623.5353
Pretty Stable
Days Of Inventory Outstanding236426193
Slightly volatile
Days Of Sales Outstanding44.4546.7965.1174
Pretty Stable
Fixed Asset Turnover6.65.645.4358
Very volatile
Debt Ratio0.06460.0680.8372
Slightly volatile
Price Sales Ratio15.8816.72118
Slightly volatile
Asset Turnover0.220.240.6764
Slightly volatile
Gross Profit Margin0.420.590.515
Slightly volatile

BioLife Solutions Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.1 B1.1 B498.8 M
Slightly volatile
Enterprise Value1.1 B1 B479.6 M
Slightly volatile

BioLife Fundamental Market Drivers

Forward Price Earnings476.1905
Cash And Short Term Investments104.6 M

BioLife Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue118.5 K112.5 K
Total Revenue94.6 M99.3 M
Cost Of Revenue32.9 M34.5 M
Stock Based Compensation To Revenue 0.43  0.41 
Sales General And Administrative To Revenue 0.57  0.54 
Research And Ddevelopement To Revenue 0.10  0.11 
Capex To Revenue 0.05  0.04 
Revenue Per Share 2.05  1.57 
Ebit Per Revenue(0.08)(0.08)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY